543635 and EQPPLPHARM Related Headlines

Go Back

Feb 2, 2026 11:00AM Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities

Nov 26, 2025 02:13PM Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities

Sep 16, 2025 07:25AM Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility

Aug 28, 2025 11:58AM Piramal Pharma Solutions Supports George Medicines in Developing its New Drug for Hypertension, WIDAPLIK™ (telmisartan, amlodipine and indapamide)

Jul 28, 2025 03:01PM Piramal Pharma Limited Announces Results for Q1FY26

Jun 30, 2025 04:10AM Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

543635 and EQPPLPHARM Related Press Releases

Go Back

Feb 2, 2026 11:00AM Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities

Nov 26, 2025 02:13PM Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities

Sep 16, 2025 07:25AM Piramal Pharma Solutions Augments Formulation Capabilities with the Addition of New Korsch XM-12 Bilayer Tablet Press at its Morpeth, UK Facility

Aug 28, 2025 11:58AM Piramal Pharma Solutions Supports George Medicines in Developing its New Drug for Hypertension, WIDAPLIK™ (telmisartan, amlodipine and indapamide)

Jul 28, 2025 03:01PM Piramal Pharma Limited Announces Results for Q1FY26

Jun 30, 2025 04:10AM Piramal Pharma Solutions Breaks Ground on $90M Expansion Plan

543635 and EQPPLPHARM Related SEC Filings

Go Back